Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B

Histopathology

Volumn 36, Issue 1, 2000, Pages 8-16

  Kaufmann, O ^a   Dietel, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Immunohistochemistry; Pulmonary carcinomas; Surfactant proteins; TTF 1

Indexed keywords

MONOCLONAL ANTIBODY; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; THYROID TRANSCRIPTION FACTOR 1;

ANTIBODY SPECIFICITY; ARTICLE; COMPARATIVE STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; MUCINOUS CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; EVALUATION STUDIES; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; NUCLEAR PROTEINS; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033971623     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.00801.x     Document Type: Article

References (25)

1. 1. Rougraff BT, Kneisel JS, Simon MA. Skeletal metastases of unknown origin. A prospective study of diagnostic strategy. J. Bone. Joint. Surg. Am. 1993; 75; 1276-1281.
2. 2. Shih LY, Chen TH, Lo WH. Skeletal metastasis from occult carcinoma. J. Surg. Oncol. 1992; 51; 109-113.
3. 3. Leonard RJ, Nystrom JS. Diagnostic evaluation of patients with carcinoma of unknown primary tumor site. Semin. Oncol. 1993; 20; 244-250.
4. 4. Colby TV, Koss MN, Travis WD. Tumors metastatic to the lung. In Colby TV, Koss MN, Travis WD eds. Tumors of the Lower Respiratory Tract. AFIP Atlas of Tumor Pathology, 3rd series, fascicle 13. Washington. D.C.: Armed Forces Institute of Pathology, 1994: 517-546.
5. 5. Askin FB. Something old? Something new? Second primary or pulmonary metastasis in the patient with known extrathoracic carcinoma. Am. J. Clin. Pathol. 1993; 100; 4-5.
6. 6. Ikeda K, Clark JC, Shaw-White JR, Stahlmann MT, Boutell CJ, Whitsett JA. Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J. Biol. Chem. 1995; 270; 8108-8114.
7. 7. Stahlman MT, Gray ME, Whitsett JA. Expression of thyroid transcription factor-1 (TTF-1) in fetal and neonatal human lung. J. Histochem. Cytochem. 1996; 44; 673-678.
8. 8. Lazzaro D, Price M, De Felice M, Di Lauro R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991; 113; 1093-1104.
9. 9. Bejarano PA, Baugham RP, Biddinger PW et al. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod. Pathol. 1996; 9; 445-452.
10. 10. Fabbro D, Di Loreto C, Stamerra O, Beltrami CA, Lonigro R, Damante G. TTF-1 gene expression in human lung tumors. Eur. J. Cancer 1996; 32A; 512-517.
11. 11. Holzinger A, Dingle S, Bejarano PA, Miller MA, Weaver TE, DiLauro R, Whitsett JA. Monoclonal antibody to thyroid transcription factor-1: production, characterization and usefulness in tumor diagnosis. Hybridoma 1996; 15; 49-53.
12. 12. Di Loreto C, Puglisi F, Di Lauro V, Damante G, Beltrami CA. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Cancer Lett. 1998; 124; 73-78.
13. 13. Nicholson AG, McCormick CJ, Shimasato Y, Butcher DN, Sheppard MN. The value of PE-10, a monoclonal antibody against pulmonary surfactant, in distinguishing primary and metastatic lung tumors. Histopathology 1995; 27; 57-60.
14. 14. Mizutani Y, Nakajima T, Morinaga S et al. Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Special reference to nonmucus producing lung adenocarcinomas. Cancer 1988; 61; 532-537.
15. 15. Shimosato Y. Pulmonary Neoplasms. In Sternberg SS ed. Diagnostic Surgical Pathology. New York; Raven Press, 1994: 1045-1093.
16. 16. Linnoila RI, Jensen SM, Steinberg SM, Mulshine JL, Eggleston JC, Gazdar AF. Peripheral airway cell marker expression in non-small cell lung carcinoma. Am. J. Clin. Pathol. 1992; 97; 233-243.
17. 17. World Health Organization. The World Health Organization histological typing of lung tumors, 2nd edn. Am. J. Clin. Pathol. 1982; 77; 123-136.
18. 18. Colby TV, Koss MN, Travis WD. Small cell carcinoma and large cell neuroendocrine carcinoma. In Colby, TV, Koss, MN, Travis WD eds. Tumors of the Lower Respiratory Tract. AFIP Atlas of Tumor Pathology, 3rd series, fascicle 13. Washington. D.C.: Armed Forces Institute of Pathology, 1994: 235-257.
19. 19. Norton AJ, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J. Pathol. 1994; 173; 371-379.
20. 20. Morgan JM, Navabi H, Schmid KW, Jasani B. Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval. J. Pathol. 1994; 174; 301-307.
21. 21. Miller RT, Kubier P. Blocking of endogenous avidin-binding activity in immunohistochemistry. The use of egg whites. Appl. Immunohistochem. 1997; 5; 63-66.
22. 22. Whittsett JA, Glasser SW. Regulation of surfactant protein gene transcription. Biochim. Biophys. Acta 1998; 1408; 303-311.
23. 23. Colby TV, Koss MN, Travis WD. Large cell carcinoma. In Colby TV, Koss MN, Travis WD eds. Tumors of the Lower Respiratory Tract. AFIP Atlas of Tumor Pathology, 3rd series, fascicle 13. Washington D.C.: Armed Forces Institute of Pathology, 1994: 259-278.
24. 24. Dunill MS, Gatter KC. Cellular heterogeneity in lung cancer. Histopathology 1986; 10; 461-475.
25. 25. Hammar SP, Bolen JW, Bockus D, Remington F, Friedman S. Ultrastructural and immunohistochemical features of common lung tumors: an overview. Ultrastruct. Pathol. 1985; 9; 283-318.